The downside is that the population may not be representative of the overall population since it is made of veterans (for example, 95% male)
The red flags on illegitimate vendors are consistent: cryptocurrency-only payment, no verifiable physical address, no certificate of analysis or third-party testing documentation, and prices dramatically below what a licensed compounding pharmacy would charge
GLP-1 is an incretin hormone naturally produced in the gut that plays a crucial role in glucose homeostasis
Dosing tiers: Morning dosing is preferred because of its stimulatory effect on cellular metabolism
Key Takeaways Starting dose: 2 mg once weekly for 4 weeks Titration pace: Increase every 4 weeks: 2 4 8 12 mg Maximum dose: 12 mg weekly (Phase 2/3 clinical trial protocol) Total ramp-up: ~16 weeks to reach maximum dose Mechanism: Triple agonist (GLP-1 + GIP + Glucagon), the only triple-agonist in late-stage trials Weight loss: Up to 24.2% at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4) GLP-3 Retatrutide Dosage Chart Free printable reference chart showing the retatrutide (GLP-3) clinical trial titration schedule from 2 mg to 12 mg weekly
Tirzepatide (Mounjaro, Zepbound) works through a similar but distinct mechanism as a dual GIP/GLP-1 receptor agonist